Application of human DSN1 gene and related products

A gene and application technology, applied in the application of human DSN1 gene and related products, can solve problems such as the lack of DSN1 gene, and achieve the effect of inhibiting proliferation, inhibiting the growth of gastric cancer, and controlling the growth process

Pending Publication Date: 2022-01-11
SHANGHAI GENECHEM
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There is no relevant report on the use of DSN1 gene in the treatment of gastric cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of human DSN1 gene and related products
  • Application of human DSN1 gene and related products
  • Application of human DSN1 gene and related products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0094] Example 1 Preparation of RNAi lentivirus against human DSN1 gene

[0095] 1. Screening for effective siRNA targets against the human DSN1 gene

[0096] Retrieve DSN1 (NM_024918) gene information from Genbank; design effective siRNA targets for DSN1 gene. Table 1-1 lists the screened effective siRNA target sequences against the DSN1 gene.

[0097] Table 1-1 is targeted at the siRNA target sequence of human DSN1 gene

[0098] SEQ ID NO TargetSeq(5'-3') 1 TGAGATGAAGGAATACATA

[0099] 2. Preparation of lentiviral vector

[0100] Aim at the siRNA target (take SEQ ID NO: 1 as an example) to synthesize a double-stranded DNA Oligo sequence (Table 1-2) with Age I and EcoR I restriction sites at both ends; Dicer acts on the pGCSIL-GFP vector (provided by Shanghai Jikai Gene Medical Technology Co., Ltd.) to linearize it, and agarose gel electrophoresis identifies the digested fragments.

[0101] Table 1-2 Double-stranded DNA Oligo with sticky ends contai...

Embodiment 2

[0120] Example 2 Real-time fluorescent quantitative RT-PCR method to detect gene silencing efficiency

[0121] Human gastric cancer AGS cells in the logarithmic growth phase were digested with trypsin to make a cell suspension (the number of cells was about 5×10 4 / ml) were inoculated in a 6-well plate and cultured until the cell confluency reached about 30%. According to the multiplicity of infection (MOI, AGS: 10), an appropriate amount of the lentivirus prepared in Example 1 was added, the culture medium was replaced after 24 hours of culture, and the cells were collected after the infection time reached 5 days. Total RNA was extracted according to the instruction manual of Invitrogen's Trizol. According to the M-MLV instruction manual of Promega Company, RNA was reverse-transcribed to obtain cDNA (see Table 2-1 for the reverse transcription reaction system, react at 42°C for 1 hour, and then bathe in a water bath at 70°C for 10 minutes to inactivate the reverse transcript...

Embodiment 3

[0129] Example 3 Detection of proliferation ability of tumor cells infected with DSN1-siRNA lentivirus

[0130] Human gastric cancer AGS cells in the logarithmic growth phase were digested with trypsin to make a cell suspension (the number of cells was about 5×10 4 / ml) were inoculated in a 6-well plate and cultured until the cell confluency reached about 30%. According to the multiplicity of infection (MOI, AGS: 10), an appropriate amount of virus was added, and the culture medium was replaced after 24 hours of culture. After the infection time reached 5 days, the cells of each experimental group in the logarithmic growth phase were collected. The complete medium was resuspended into a cell suspension (2×10 4 / ml), inoculate a 96-well plate at a cell density of about 3000 / well. 5 replicate wells in each group, 100 μl per well. After laying the board, place at 37°C, 5% CO 2 Incubator cultivation. From the second day after plating, the plate was detected and read once a da...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biological medicine research, and particularly relates to application of a human DSN1 gene as a target in preparation of gastric cancer treatment drugs or gastric cancer diagnosis drugs. Through extensive and deep research, proliferation of gastric cancer cells can be effectively inhibited after expression of the human DSN1 gene is reduced by adopting an RNAi method, cell apoptosis is promoted, and the growth process of gastric cancer can be effectively controlled. The siRNA or the nucleic acid construct containing the siRNA sequence and the lentivirus provided by the invention can specifically inhibit the proliferation capacity of gastric cancer cells and inhibit the growth of gastric cancer, so that the gastric cancer is treated, and a new direction is opened up for gastric cancer treatment.

Description

technical field [0001] The invention belongs to the field of biomedical research, and specifically relates to the use of human DSN1 gene and related products. Background technique [0002] Studies have found that the DSN1 gene is related to colorectal cancer and liver cancer. In one study, genome-wide SNP genotyping and RNA-seq analysis of colon tissue from a single patient identified 68 genes with differential copy number alterations and progressive dysregulation in colorectal cancer. Among them, the protein levels of Aurora A, SKA3 and DSN1 were up-regulated sequentially, and the loss of SKA3 or DSN1 resulted in G2 / M arrest and decreased migration and invasion. Another study found that DSN1 was also expressed in liver cancer. Through QPCR and immunohistochemistry, the results showed that the expression of DSN1 was up-regulated in liver cancer tissues, and it was correlated with gender, alpha-fetoprotein, tumor size, number of tumor nodules, tumor thrombus, and degree of d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886G01N33/574A61K45/00A61K31/713A61P35/00C12N15/113C12N15/867
CPCC12Q1/6886G01N33/57446G01N33/5748A61K45/00A61P35/00C12N15/1135C12N15/86C12Q2600/158C12Q2600/136C12N2310/14C12N2320/32C12N2740/15043C12N2800/107C12N2310/531
Inventor 黄娴曹跃琼
Owner SHANGHAI GENECHEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products